Please use this identifier to cite or link to this item: http://hdl.handle.net/10668/3148
Title: Oral administration of the cannabigerol derivative VCE-003.2 promotes subventricular zone neurogenesis and protects against mutant huntingtin-induced neurodegeneration
Authors: Aguareles, José
Paraíso-Luna, Juan
Palomares, Belén
Bajo-Grañeras, Raquel
Navarrete, Carmen
Ruiz-Calvo, Andrea
García-Rincón, Daniel
García-Taboada, Elena
Guzmán, Manuel
Muñoz, Eduardo
Galve-Roperh, Ismael
metadata.dc.contributor.authoraffiliation: [Aguareles,J; Paraíso-Luna,J; Bajo-Grañeras,R; Ruiz-Calvo,A; García-Rincón,D; García-Taboada,E; Guzmán,M; Galve-Roperh,I] Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain. [Aguareles,J; Paraíso-Luna,J; Bajo-Grañeras,R; Ruiz-Calvo,A; García-Rincón,D; García-Taboada,E; Guzmán,M; Galve-Roperh,I] Departamento de Bioquímica y Biología Molecular and Instituto Universitario de Investigación Neuroquímica, Universidad Complutense, Madrid, Spain. [Aguareles,J; Paraíso-Luna,J; Bajo-Grañeras,R; Ruiz-Calvo,A; García-Rincón,D; García-Taboada,E; Guzmán,M; Galve-Roperh,I] Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain. [Palomares,B; Muñoz,E] Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, Spain. [Palomares,B; Muñoz,E] Departamento de Biología Celular, Fisiología e Inmunología, Universidad de Córdoba, Córdoba, Spain. [Palomares,B; Muñoz,E] Hospital Universitario Reina Sofía, Córdoba, Spain. [Navarrete,C] Emerald Health Pharmaceuticals, San Diego, USA.
Keywords: Cannabinoid;Huntingtin;Neurodegeneration;Neurogenesis;PPAR;Cannabinoides;Proteína huntingtina;Enfermedades neurodegenerativas;Neurodegenerative diseases;Neurogénesis;Peroxisome proliferator-activated receptors;Receptores activados del proliferador del peroxisoma
metadata.dc.subject.mesh: Medical Subject Headings::Diseases::Nervous System Diseases::Neurodegenerative Diseases
Medical Subject Headings::Chemicals and Drugs::Organic Chemicals::Hydrocarbons::Terpenes::Cannabinoids
Medical Subject Headings::Phenomena and Processes::Cell Physiological Phenomena::Cell Physiological Processes::Cell Differentiation::Neurogenesis
Medical Subject Headings::Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Proteins::Receptors, Cytoplasmic and Nuclear::Peroxisome Proliferator-Activated Receptors
Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans
Issue Date: 8-Mar-2019
Publisher: BioMed Central Ltd.
Citation: Aguareles J, Paraíso-Luna J, Palomares B, Bajo-Grañeras R, Navarrete C, Ruiz-Calvo A, et al. Oral administration of the cannabigerol derivative VCE-003.2 promotes subventricular zone neurogenesis and protects against mutant huntingtin-induced neurodegeneration. Transl Neurodegener. 2019 Mar 8;8:9.
Abstract: The administration of certain cannabinoids provides neuroprotection in models of neurodegenerative diseases by acting through various cellular and molecular mechanisms. Many cannabinoid actions in the nervous system are mediated by CB1 receptors, which can elicit psychotropic effects, but other targets devoid of psychotropic activity, including CB2 and nuclear PPARγ receptors, can also be the target of specific cannabinoids.
URI: http://hdl.handle.net/10668/3148
metadata.dc.relation.publisherversion: https://translationalneurodegeneration.biomedcentral.com/articles/10.1186/s40035-019-0148-x
metadata.dc.identifier.doi: 10.1186/s40035-019-0148-x
ISSN: 2047-9158 (Online)
Appears in Collections:01- Artículos - Hospital Reina Sofía
01- Artículos - IMIBIC. Instituto Maimónides de Investigación Biomédica de Córdoba

Files in This Item:
File Description SizeFormat 
Aguareles_OralAdministrationOfThe.pdfArtículo publicado9,45 MBAdobe PDFView/Open


This item is protected by original copyright



This item is licensed under a Creative Commons License Creative Commons